PCI Biotech Semi Variance
| PCIB Stock | | | NOK 0.16 -0.02 -11.11% |
The Semi Variance calculation for PCI Biotech draws on price and volume history. Additional screening context is available through
Equity Screeners. PCI Biotech has a market cap of 81.93 M, operating margin of -15.29%, current ratio of 16.24. See
Your Equity Center for additional portfolio context. Including PCI Biotech Holding in a portfolio enables allocation and risk analysis. All figures are based on reported data and are informational in nature. Broader economic conditions can influence PCI Biotech Holding's company valuation — related indicators include
signals in inflation.
PCI Biotech Holding has current Semi Variance of 94.82. Semi-variance provides a good measure of downside volatility for equity or a portfolio. It is similar to variance, but it only looks at periods where the returns are less than the target or average level.
Semi Variance | = | SUM(RET DEV)2N(ZERO) |
| = | 94.82 | |
| SUM | = | Summation notation |
| RET DEV | = | Actual return deviation over selected period |
| N(ZERO) | = | Number of points with returns less than zero |
Semi Variance Peers Comparison
Semi Variance Relative To Other Indicators
PCI Biotech Holding sits atop the peer group for semi variance within its peer group. It is currently under evaluation for maximum drawdown within its peer group where Maximum Drawdown runs almost
1.45 per Semi Variance.
Semi-variance is the square of semi-deviation. Semi-variance is calculated by averaging the deviations of returns that have a result that is less than the mean.
Compare PCI Biotech to Peers
Other Technical Indicators